Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas

Archives of Otolaryngology - Head and Neck Surgery

Volumn 122, Issue 11, 1996, Pages 1261-1265

  Bid, Merrill A ^a  

^a Minneapolis Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; PHOTOFRIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERIPHERAL NEUROPATHY; PHOTODYNAMIC THERAPY; RECURRENT CANCER; SKULL BASE TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

EID: 0029904596     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1996.01890230105018     Document Type: Article

References (28)

1. DeSanlo LW, Beahrs OH, Holt JJ, O'Fallon J. Neck dissection and combined therapy: a study of effectiveness. Arch Otolaryngol Head Neck Surg. 1985:111:366-370.
2. Johnson JT, Barns EL, Myers EN, Schramm VL, Borochovitz D, Sigler BA. Trie extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol. 1981:107:725-729.
3. Chu W, Strawitx JG. Results of suprahyoid, modified radical and standard radical neck dissections for metastatic squamous cell carcinoma: recurrence and survival. Am J Surg. 1978,136: 512-515.
4. Bartelink H, Breur K, Hart G, Annyas B, van Slooten E, Snow G. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer. 1983:52:1008-1013.
5. Razack MS, Sako K, Kalnins I. Squamous cell carcinoma of the pyriform sinus. Head Neck Surg. 1978:1:31-34.
6. Carpenter RJ, DeSanto LW, Devine KD, Taylor WF. Cancer of the hypopharynx: analysis of treatment and results in 162 patients. Arch Otolaryngol. 1976:102:716-721.
7. Foote RL, Olsen KD, Davis DL, et al. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head Neck Surg. 1983:15:300-307.
8. Biel MA. Photodynamic therapy of head and neck cancers. Semin Surg Oncol. 1995:11:355-359.
9. Biel MA, Janssen W, Trump MF. Photodynamic therapy to the oral cavity, tongue and larynx: a canine normal tissue tolerance study. Lasers Med Sei. 1995:10:13-18.
10. Nakajima S, Takemura T. Fundamental Studies on the Tumor-Localizing Properties of PhotoIrin II. Asahikawa, Japan: Asahikawa Medical College Press; 1992:1-20.
11. Moan J, Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol. 1992;55:931-948.
12. Roberts WG, Hasan T. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res. 1992; 52:924-930.
13. Weishaupt K, Corner C, Dougherty T. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976:36:2326-2329.
14. Moan J, Pettersen EO, Christensen T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of hematoporphyrin. BrJ Cancer. 1979:39:398-407.
15. Tatsuta M, Yamamoto R, Yamamura H, et al. Photodynamic effects of exposure to hematoporphyrin derivatives and dye-laser radiation on human gastric adenocarcinoma cells. JtJatl Cancer Inst. 1984:73:59-67.
16. Foote C. Mechanisms of photooxygenation. In: Doiron D, Gomer C, eds. Porphyrin Localization and Treatment of Tumors. New York, NY: Alan R Liss Inc; 1984:3-18.
17. Athar M, Mukhtar H, Elmets CA, Zaim MT, Lloyd J, Bickers D. In situ evidence for the involvement of Superoxide anions in cutaneous porphyrin photosensitization. Biochem Biophys Res Commun. 1988:151:1054-1059.
18. Lee-See K, Forbes l, Betts W. Hydroxyl radical production by hematoporphyrin derivative. Aust Soc Med Res. 1985:127:32. Abstract.
19. Hariharan PV, Courtney J, Eleczko S. Production of hydroxyl radicals in cell systems exposed to hematoporphyrin and red light. Int J Radiât Biol. 1980:37:691-694.
20. Athar M, Elmets CA, Bickers DR, Mukhtar H. A novel mechanism for the generation of superoxide anions in hematoporphyrin derivativemediated cutaneous photosensitization. J Clin Invest. 1989:83:1137-1143.
21. Kreimer-Birnbaum M, Klaunig J, Keck R, Goldblatt P, Britton S, Selman S. Studies with hematoporphyrin derivative in transplantable urothelial tumors. In: Andreoni AS, Cabeddu R, eds. Porphyrins in Tumor Phototherapy. New York, NY: Plenum Publishing Corp; 1984:235-241.
22. Selman S, Kreimer-Birnbaum M, Klaunig J, Goldblatt P, Keck R, Britton S. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 1984; 44:1924-1927.
23. Star W, Marijnissen H, van den Berg-Blok A, Versteeg J, Franken K, Reinhold H. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in Sandwich observation chambers. Cancer Res. 1986:46:25322540.
24. Selman SH, Milligan A, Kreimer-Bimbaum M, Keck R, Goldblatt P, Britton S. Hematoporphyrin derivative photochemotherapy of experimental bladder tumors. J Uni. 1985;133:330-333.
25. Fingar V, Henderson B. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem Photobiol. 1987;46:837-841.
26. Moore RB, Chapman JD, Mokrzanowski AD, Arnfield MR, McPhee MS, McEwan AJ. Noninvasive monitoring of photodynamic therapy with technetium HMPAO scintigraphy. Br J Cancer. 1992:65:491-497.
27. Shulock J, Klaunig J, Selman S, Schafer P, Goldblatt P. Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells. AmJPathol. 1986:122: 277-283.
28. Nelson J, Liaw L, Orenstein A, Roberts W, Berns M. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. JNatlCancerlnst. 1988:80:1599-1605.